The rapidly evolving evidence base for COVID-19 treatment and management presents a challenge to guidelines developers. MAGICapp enables the rapid update and dissemination of guidelines, with detailed version control to manage evolving content.
MAGIC is therefore committed to support organizations during the COVID-19 pandemic, as exemplified by the collaboration with the World Health Organisation – enhanced by the BMJ Rapid Recommendations - the Australian National COVID-19 Clinical Evidence Taskforce - and the National Institute for Health and Care Excellence (NICE) in the UK.
These collaborations have resulted in trustworthy and living guidelines developed, published and dynamically updated through MAGICapp. The guidelines also build on living systematic reviews - including Living Network Meta-Analysis - and demonstrate the potential of a more trustworthy, efficient and integrated evidence ecosystem.
To further tackle the COVID-19 pandemic MAGIC is offering the MAGICapp platform at no charge to organizations that are unable to pay a license fee. Contact us to set up an account and immediately start developing and publishing your COVID-19 guidelines.
"This new guideline is the latest development in our ongoing response to the COVID-19 pandemic. The pandemic has driven new collaborative and international ways of working, and by sharing high-quality evidence with our colleagues around the world in the MAGICapp platform we have been able to develop this guidance more quickly. Being able to identify and assess the latest global evidence in a platform like MAGICapp will also help us to more efficiently identify which guidance needs updating as we continue to support healthcare professionals caring for COVID-19 patients."
Professor Gillian Leng
NICE Chief Executive (2020-2022)